ANCA-Negative Pauci-Immune GN — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — ANCA-negative pauci-immune glomerulonephritis – treat as ANCA vasculitis
Approximately 10-20% of pauci-immune crescentic/necrotising GN is ANCA-negative by conventional assays. These patients are managed identically to ANCA-positive vasculitis per KDIGO 2024, as the histology and clinical behaviour are similar. Some patients may have antibodies detectable by research assays only. Treatment with glucocorticoids plus Rituximab or Cyclophosphamide is recommended. Response rates and prognosis are comparable to ANCA-positive disease.
Reference: KDIGO 2024 – ANCA-Associated Vasculitis; Chen et al 2007 – ANCA-Negative Vasculitis